Screening Optimal Candidates With Operable Early-Stage TNBC Benefitting From Capecitabine Maintenance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study
Breast 2024 May 06;76(xx)103740, F Duan, X Hua, X Bi, S Wang, Y Shi, F Xu, L Wang, J Huang, Z Yuan, Y HuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.